about
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisGenetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial.The CD20 homologue MS4A4 directs trafficking of KIT toward clathrin-independent endocytosis pathways and thus regulates receptor signaling and recyclingHousekeeping and tissue-specific genes in mouse tissues.Phylogenetic analysis of the MS4A and TMEM176 gene familiesMS4a4B, a CD20 homologue in T cells, inhibits T cell propagation by modulation of cell cycle.Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motifA novel FcεRIβ-chain truncation regulates human mast cell proliferation and survivalTargeted ablation of miR-21 decreases murine eosinophil progenitor cell growth.Transcriptional heterogeneity of IgM+ cells in rainbow trout (Oncorhynchus mykiss) tissues.TCR stimulation upregulates MS4a4B expression through induction of AP-1 transcription factor during T cell activation.Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.Expression of MS4A and TMEM176 Genes in Human B LymphocytesCharacterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissuesDeficiency of GRP94 in the hematopoietic system alters proliferation regulators in hematopoietic stem cells.EVI1 promotes tumor growth via transcriptional repression of MS4A3.siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts.The MS4A family: counting past 1, 2 and 3.Changes in transcriptome of macrophages in atherosclerosis.MS4A4A: a novel cell surface marker for M2 macrophages and plasma cells.Anti-MS4a4B treatment abrogates MS4a4B-mediated protection in T cells and ameliorates experimental autoimmune encephalomyelitis.Identification of the novel differentiation marker MS4A8B and its murine homolog MS4A8A in colonic epithelial cells lost during neoplastic transformation in human colonCD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.3,5-disubstituted thiadiazine-2-thiones: new cell-cycle inhibitors.Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A.Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia.An update on vitamin B12-related gene polymorphisms and B12 status.Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia.
P2860
Q27851621-5B24213B-191A-4999-8B6C-4B197F868DC6Q28553797-9C395859-8ECB-4C52-8421-76FE7ADBC51DQ30411208-52C0ACA0-7D35-41F6-B294-A5E4609F5544Q30565546-27DE3A3F-30D6-4DFB-BDBA-EC055863A4F0Q33285439-3D9F486B-E195-46CC-95DC-AE8F4C259D4BQ33534692-809284C1-C4B7-40F3-8D63-7C33D610028BQ33745039-D4DAA7D9-C768-4ECB-BD84-701B3FAAB85DQ33846983-FBAD1A2D-A0DE-4BD1-8D6D-E5DD0A778C47Q34378845-E2D87C55-E2B7-4E44-8C2F-17DD9C9A75DEQ34637817-2745D452-B421-412D-9DC7-625F138E5DA8Q35064296-0AEFA8D6-1501-4367-AFF7-CE3B0B345556Q35892571-D55E7181-523B-4C9A-AF87-58F734C65B2AQ36629461-4A61AC22-8127-42C8-9139-D6A8B18F8AE8Q37011495-63569136-0DE4-4833-9E9E-1EF04A97D93BQ37293778-295ABA9D-03F4-4647-BAA3-769DA0D292F6Q37377770-1CDC8F23-5EE6-49C4-B5F1-D0C9BB2B1B9FQ38299701-A35DE678-C155-4549-86FB-D9F4803CB16FQ38313725-955ED1A8-A739-4EDF-B92F-E208526011D7Q38401877-B338C440-2B09-49BC-8212-92CD162D27E3Q38479492-AC1D35E1-70CC-42F7-BA25-DF8CD43D1AE1Q38711882-45BFB273-8F0C-423C-B5BC-42C9FDB650EFQ39134948-E7625812-B35F-494A-9B56-E531B30D97EEQ39205168-E4E753C2-196F-409F-8117-F4C596B0BB16Q39313119-2734C01E-7ACD-404E-BF72-D6057C37429EQ39402992-AD50EA5D-E6D8-43EA-9C52-7D44296C0339Q39658224-DEB68D96-D7A0-44DA-AC76-9EE4EF57D1F7Q40239647-B16142EC-8AFD-4B6C-A091-1AE4577B7892Q50256416-3C02CE6B-93A0-4C5E-B9E8-CEFA2C767453Q55261830-49EA22B2-9C53-4676-8376-62F378D1F98C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Human HTm4 is a hematopoietic cell cycle regulator
@ast
Human HTm4 is a hematopoietic cell cycle regulator
@en
Human HTm4 is a hematopoietic cell cycle regulator
@nl
type
label
Human HTm4 is a hematopoietic cell cycle regulator
@ast
Human HTm4 is a hematopoietic cell cycle regulator
@en
Human HTm4 is a hematopoietic cell cycle regulator
@nl
prefLabel
Human HTm4 is a hematopoietic cell cycle regulator
@ast
Human HTm4 is a hematopoietic cell cycle regulator
@en
Human HTm4 is a hematopoietic cell cycle regulator
@nl
P2093
P2860
P3181
P1476
Human HTm4 is a hematopoietic cell cycle regulator
@en
P2093
Chaker N Adra
David Beach
David T Scadden
Jeffery L Kutok
José L Donato
Mohamed H Sayegh
Taro Shirakawa
Xiao-Quan Mao
P2860
P3181
P356
10.1172/JCI0214025
10.1172/JCI14025
P407
P577
2002-01-01T00:00:00Z